as 03-25-2025 11:39am EST
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Founded: | 1943 | Country: | United States |
Employees: | N/A | City: | WAYNE |
Market Cap: | 8.3B | IPO Year: | N/A |
Target Price: | $193.88 | AVG Volume (30 days): | 2.0M |
Analyst Decision: | Hold | Number of Analysts: | 9 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 1.48 | EPS Growth: | -80.36 |
52 Week Low/High: | $128.55 - $249.91 | Next Earning Date: | 05-01-2025 |
Revenue: | $3,047,324,000 | Revenue Growth: | 2.45% |
Revenue Growth (this year): | 3.37% | Revenue Growth (next year): | 4.13% |
TFX Breaking Stock News: Dive into TFX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
StockStory
2 days ago
Morningstar Research
5 days ago
Insider Monkey
8 days ago
StockStory
9 days ago
MT Newswires
16 days ago
Simply Wall St.
17 days ago
Motley Fool
17 days ago
The information presented on this page, "TFX Teleflex Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.